GCETMBA.com - Business News Update


Bangalore INDIA BIO 2010
Started in the Year 2001, Bangalore Bio, now Bangalore INDIA BIO, has emerged as India's biggest national event attracting participation from Biotech, Pharma & allied industries, Research institutes and all the major Biotech States. Bangalore INDIA BIO is now recognized as the Gateway to India generating tremendous interest and response worldwide from leading Bio Nations like USA, Canada, UK, France, Germany, Spain, Australia, New Zealand, Cuba, South Africa, Japan, Singapore, China, Korea and UAE.
Bioserve Biotechnologies (India) Pvt Ltd Accredited For GMO Testing By NABL
BioServe develops cost effective, PCR based GMO screening tests for exporters of food and agri product, positioning itself as an emerging player in the Rs. 1500 cr. global Food Safety Testing market.
GVK Biosciences receives AAALAC Accreditation for its Animal Facility
GVK Biosciences Private Limited (GVK BIO), Asia's leading Contract Research Organization today announced that it received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International for its animal facilities.
Synergy Diagnostics Voted as Excellence Innovators in Blood & Biological Products!!!
Award Alert: Over 12, 345 Votes Cast In All Categories : Vote Live At www.pharmaleaders.co.in
Traditional Knowledge of Indigenous Plant Lost by Indian Government
Traditional Knowledge of the medicinal qualities of an indigenous plant was known only to a tribal people of only 20,000. When Indian Government learned of this Traditional Knowledge, it mishandled the results under the intellectual property laws of India. Results of the Government's action lost the plant to all concerned, even the tribal people.
Global Market for Biotechnologies for Medical Applications to Be Worth $222.9 Billion In 2015
The value of the market for biotechnologies for medical applications was an estimated $123.2 billion in 2010, but is expected to increase to nearly $223 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 12.6%.
Camson Biotech rides on rising demand for hybrid seeds, bio-fertilizers and biocides to deliver record growth of 814% in Q4
Net annual income grows by 63% to Rs 80 crore. Annual Net Profit grows by 85% to Rs 15 crore.
Stempeutics announces clinical trial outcome of India's FIRST stem cell product "Stemepucel-CLI"
Establishes strategic alliance with Cipla for product marketing
Global Market of Biological Therapies for Cancer to Be Worth $54 Billion In 2014
The global market value of biological therapies for cancer was an estimated $37.8 billion in 2009, but is expected to increase to $53.8 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 7.2%.
"USING PATENTS FOR COMPETITIVE ADVANTAGE"- A Seminar for Biotech / Pharma Industry organized by Intellecture on 23rd April in Bangalore
In order to provide Biotechnology and Pharma companies that biting edge in business over the competitors, Intellecture Brain League's training division has organized a seminar "USING PATENTS FOR COMPETITIVE ADVANTAGE" on April 23rd in Bangalore.
Hikal Won Prestigious ABCI Award for the Third Consecutive Year
The company has won the ABCI (Silver) Award for its Annual Report 2007- 2008
Celon Labs makes women commuters feel special on International Women's Day!
Celon Labs provides free bus ride for women commuters Greets women & lady doctors with roses
Minister for Health and Tourism of Gujarat state visited Veeda's unit in MPUH
Minister for Health and Tourism of Gujarat state visited Veeda's unit in MPUH during the inauguration ceremony of the Uro-Oncology conference
Veeda announces the appointment of Mr. Venu Madhav as the new COO
Veeda Clinical Research announced the appointment of Mr. Venu Madhav as the new Chief Operating Officer of its unit in India.
India FRP pipes & tanks market to grow 23.8% by 2015
The estimated growth rate of the India FRP pipes & tanks market has been about 32% (by value) since 2009. It is further anticipated that India FRP pipes & tanks industry would grow at a compound annual growth rate of 23.8% for the period 2010-15
From Oceans to Crops, and From Crops to IPO - Avesthagen's systems biology approach to novel products targets more than land based organisms - dives deep into new products from the Ocean
Approximately 600 patent applications cover both, process and products.
Catalyz bags national award for Best Start up Biotechnology/Pharma Company
Catalyz Scientific Technologies incubated at Technopark Trivandrum TBI won national award for the best start up company in Biotech/Pharma sector for the year 2009.
Bharat Bio Vaccine Doses Touch 1 Billion
Bharat Biotech is a global manufacturer of vaccines to protect against rabies, polio, hepatitis-B, typhoid, diphtheria, pertussius, tetanus, haemophilus influenza B and other diseases.
Revolutionary Swedish Invention Can Potentially Improve Drug Development
Attana AB introduces the Attana Cell 200 - the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.
Looking Good! Avesthagen granted Patent Registration for its Trapezoidal design under sub-category 09 -03
Avesthagen Limited was granted registration for its appealing and innovative trapezoidal design by the Indian Patents Office. The sub-category 09-03 includes Boxes, Cases, Containers, (Preserve) Tins and Cans and is effective from Jan 31, 2008.
Jubilant Q3 results : Jubilant Organosys to further sharpen its focus on Pharma & Life Sciences business by demerging its Agri and Performance Polymer business
Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, today announced the business reorganization and its financial results for Q3 & 9M FY2010
Global Biochip Markets: Microarrays and LAB-ON-A-CHIP
The global market value for biochip products is an estimated $2.6 billion in 2009, but is expected to increase to nearly $6 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 17.7%.
ISCR 3rd Annual Conference in Bangalore established advances in clinical research and highlighted new benchmarks for the clinical research industry
The Indian Society for Clinical Research (ISCR) concluded its 3rd Annual Conference in Bangalore on January 9, 2010. The speaker sessions and the participants' attendance all reflected the immense interest in the trends, challenges and opportunities within the clinical research space, as it seeks to be a sector power house, not just in India but also globally. Focusing on the inter-dependability of science, business and society, the conference speakers discussed the various aspects of drug development that involved these three realms.
ISCR 3rd Annual Conference in Bangalore inaugurated today
Inauguration by ISCR President, Dr Arun Bhatt with IPA President Dr B Suresh Launch of a quarterly journal and featured tracks by national/ international experts
Clinigene deploys SAS Clinical Data Management solution to accelerate clinical research
SAS, the leader in business analytics software and services, today announced that Clinigene International Limited, a full-service Clinical Research Organization that partners with global pharmaceutical and biotechnology companies, has deployed SAS Clinical Data Management - PheedIt solution to accelerate clinical research. SAS PheedIt is a highly efficient, cost effective and easy-to-use clinical data management solution (CDMS).
RMS Regrow's Cartilage Cell Treatment Helps State Level Cricketer to Return Back to Form
To illustrate the use and benefit of advanced cell therapy for treating sports injuries, Regenerative Medical Services Regrow (RMS Regrow), a leading Indian Stem Cell Therapy Services organisation, and Dr. Anant Joshi, a renowned Orthopedic Surgeon with a specialisation in Arthroscopy, Sports Medicine and Fitness Management, shared the success story of Ankit Parashar, State level (Madhya Pradesh) Cricketer, at the Cricket Club of India. Working together, Dr. Anant Joshi and RMS Regrow were able to successfully eradicate the pain using cartilage cell therapy, and after routine rehabilitation, Ankit Parashar would be back in action to play cricket by next month.
Global Market for Equipment used in Biotechnology Applications
The global market value for biotechnology equipment is an estimated $5.5 billion in 2009, but is expected to increase to nearly $7.3 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 5.8%. The largest segment of the market, imaging, is expected to increase at a 5-year CAGR of 4.9%, from $1.7 billion in 2009 to $2.1 billion in 2014.